1. Home
  2. TELO vs PFO Comparison

TELO vs PFO Comparison

Compare TELO & PFO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TELO
    SELLHOLDBUYas of 15 hours ago
  • PFO
    SELLHOLDBUYas of 15 hours ago
  • Stock Information
  • Founded
  • TELO 2021
  • PFO 1991
  • Country
  • TELO United States
  • PFO United States
  • Employees
  • TELO N/A
  • PFO N/A
  • Industry
  • TELO
  • PFO Finance Companies
  • Sector
  • TELO
  • PFO Finance
  • Exchange
  • TELO NYSE
  • PFO Nasdaq
  • Market Cap
  • TELO 124.1M
  • PFO 123.7M
  • IPO Year
  • TELO 2024
  • PFO N/A
  • Fundamental
  • Price
  • TELO $4.67
  • PFO $9.08
  • Analyst Decision
  • TELO
  • PFO
  • Analyst Count
  • TELO 0
  • PFO 0
  • Target Price
  • TELO N/A
  • PFO N/A
  • AVG Volume (30 Days)
  • TELO 249.5K
  • PFO 31.8K
  • Earning Date
  • TELO 02-12-2025
  • PFO 01-01-0001
  • Dividend Yield
  • TELO N/A
  • PFO 6.51%
  • EPS Growth
  • TELO N/A
  • PFO N/A
  • EPS
  • TELO N/A
  • PFO N/A
  • Revenue
  • TELO N/A
  • PFO N/A
  • Revenue This Year
  • TELO N/A
  • PFO N/A
  • Revenue Next Year
  • TELO N/A
  • PFO N/A
  • P/E Ratio
  • TELO N/A
  • PFO N/A
  • Revenue Growth
  • TELO N/A
  • PFO N/A
  • 52 Week Low
  • TELO $3.11
  • PFO $6.90
  • 52 Week High
  • TELO $20.72
  • PFO $8.51
  • Technical
  • Relative Strength Index (RSI)
  • TELO 47.45
  • PFO 38.46
  • Support Level
  • TELO $4.35
  • PFO $9.01
  • Resistance Level
  • TELO $5.39
  • PFO $9.28
  • Average True Range (ATR)
  • TELO 0.68
  • PFO 0.09
  • MACD
  • TELO -0.04
  • PFO -0.01
  • Stochastic Oscillator
  • TELO 23.13
  • PFO 23.33

Stock Price Comparison Chart: TELO vs PFO

TELO
PFO
AprilJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober01234567891011121314TELO VS PFO

About TELO TELOMIR PHARMACEUTICALS INC

Telomir Pharmaceuticals Inc is a pre-clinical-stage pharmaceutical company focused on the development and commercialization of TELOMIR-1, a novel small molecule being developed to function as an oral in situ therapeutic treatment for human stem cells.

About PFO Flaherty & Crumrine Preferred and Income Opportunity Fund Incorporated

Flaherty & Crumrine Prfd Income Oppo is the United States-based diversified, closed-end investment company. Its primary investment objective is to produce high current income consistent with the preservation of capital. The fund invests in a diversified portfolio of preferred securities which includes traditional preferred stocks eligible for the inter-corporate dividends received a deduction and fully taxable preferred securities.

Share on Social Networks:

By browsing this website, you accept our Privacy Policy & Terms of Use